• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者心房利钠肽分子模式的变化

Changes in molecular pattern of atrial natriuretic peptide in hemodialysis patients.

作者信息

Akiba T, Ando K, Marumo F

机构信息

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

出版信息

Int J Artif Organs. 1994 Nov;17(11):585-90.

PMID:7744518
Abstract

An attempt was made to clarify whether the molecular forms of atrial natriuretic peptide (ANP) in the plasma of stable hemodialysis patients differ from those of healthy volunteers, and whether the ANP molecular forms in plasma might change during hemodialysis treatment. Ten stable hemodialysis patients with no clinical signs of cardiac disease were treated for 4 hours by a hollow fiber-type dialyzer. Plasma ANP concentrations before dialysis were 210 +/- 101.6 pg/ml (mean +/- SD), which were significantly higher than that of volunteers (59.2 +/- 37.2 pg/ml, n = 25). They were significantly decreased to 71.6 +/- 60.1 pg/ml after dialysis. Molecular patterns of ANP were measured by gel permeation chromatography and reverse-phase high performance liquid chromatography. Immunoreactive alpha-ANP peaks of GPC, which co-migrated with authentic alpha-, beta-, and gamma-ANP, were supposed to be alpha-, beta-, and gamma-ANP. The plasma of four patients contained a beta-ANP peak before dialysis, and three of the four still contained a beta-ANP peak after dialysis. These results showed that the middle-molecular-weight ANP, which co-migrated with authentic beta-ANP and is supposed to be beta-ANP, may particularly be secreted in clinically stable hemodialysis patients.

摘要

本研究旨在阐明稳定血液透析患者血浆中心房利钠肽(ANP)的分子形式是否与健康志愿者不同,以及血浆中的ANP分子形式在血液透析治疗过程中是否会发生变化。10名无心脏病临床症状的稳定血液透析患者使用中空纤维型透析器进行了4小时的治疗。透析前血浆ANP浓度为210±101.6 pg/ml(平均值±标准差),显著高于志愿者(59.2±37.2 pg/ml,n = 25)。透析后显著降至71.6±60.1 pg/ml。通过凝胶渗透色谱法和反相高效液相色谱法测量ANP的分子模式。凝胶渗透色谱法中与真实的α-、β-和γ-ANP共迁移的免疫反应性α-ANP峰被认为是α-、β-和γ-ANP。4名患者的血浆在透析前含有β-ANP峰,其中3名患者在透析后仍含有β-ANP峰。这些结果表明,与真实β-ANP共迁移且被认为是β-ANP的中分子量ANP可能在临床稳定的血液透析患者中特别分泌。

相似文献

1
Changes in molecular pattern of atrial natriuretic peptide in hemodialysis patients.血液透析患者心房利钠肽分子模式的变化
Int J Artif Organs. 1994 Nov;17(11):585-90.
2
Circulating and excreted forms of atrial natriuretic peptide in healthy subjects and patients with renal diseases.健康受试者和肾病患者中循环及排泄形式的心房利钠肽
Clin Nephrol. 1992 Oct;38(4):203-8.
3
Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.慢性肾衰竭患者血液透析期间脑钠肽和心房钠尿肽血浆浓度的变化
Horm Metab Res. 1994 May;26(5):246-9. doi: 10.1055/s-2007-1001675.
4
Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.慢性肾衰竭患者血浆心房利钠肽水平
J Clin Endocrinol Metab. 1986 Oct;63(4):819-22. doi: 10.1210/jcem-63-4-819.
5
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.血液透析治疗前后患者中利钠肽原的N端片段
Kidney Int. 2000 Jul;58(1):374-83. doi: 10.1046/j.1523-1755.2000.00175.x.
6
Gamma-atrial natriuretic polypeptide (gamma ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alpha ANP.人血浆中γ-心房利钠多肽(γ-ANP)衍生肽:N端γ-ANP片段与α-ANP的共分泌
J Clin Endocrinol Metab. 1988 Sep;67(3):429-37. doi: 10.1210/jcem-67-3-429.
7
Changes of molecular forms of atrial natriuretic peptide after treatment for congestive heart failure.充血性心力衰竭治疗后心房利钠肽分子形式的变化
Klin Wochenschr. 1988 Aug 1;66(15):675-81. doi: 10.1007/BF01726925.
8
Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure.
Endocr J. 1993 Apr;40(2):257-61. doi: 10.1507/endocrj.40.257.
9
Plasma atrial natriuretic peptide: concentrations and circulating forms in normal man and patients with chronic renal failure.血浆心钠素:正常人和慢性肾功能衰竭患者的浓度及循环形式
Clin Exp Pharmacol Physiol. 1987 Feb;14(2):95-102. doi: 10.1111/j.1440-1681.1987.tb00962.x.
10
Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.终末期肾病患者血浆中心房利钠肽、精氨酸加压素及肾素-血管紧张素系统激素的浓度
Int J Artif Organs. 1989 Mar;12(3):153-8.

引用本文的文献

1
Molecular forms of natriuretic peptides in heart failure and their implications.心力衰竭中心钠肽的分子形式及其意义。
Heart. 2010 Mar;96(6):419-24. doi: 10.1136/hrt.2008.164145. Epub 2009 May 17.